Adenoma Detection Rate and Colorectal Cancer Risk in Fecal Immunochemical Test Screening Programs : An Observational

Manuel Zorzi1, Giulio Antonelli2, Claudio Barbiellini Amidei1

  • 1Veneto Tumor Registry, Azienda Zero, Padova, Italy (M.Z., C.B.A., J.B.).

Annals of Internal Medicine
|February 21, 2023
PubMed
Summary

Higher adenoma detection rates (ADR) in colonoscopies following positive fecal immunochemical tests (FITs) are linked to reduced postcolonoscopy colorectal cancer (PCCRC) risk. Improving endoscopist ADR is crucial for enhancing CRC screening program effectiveness.